# ALIMERA SCIENCES INC

ALIMERA SCIENCES INC is a company headquartered in Alpharetta, GA, United States.

## Company overview

- **Legal name:** ALIMERA SCIENCES INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Alpharetta, GA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001267602

## About

ALIMERA SCIENCES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001267602, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-08, it reported annual revenue of USD 80,754,000; net income of USD -20,132,000; total assets of USD 153,524,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $80.8M (USD 80,754,000)
- **Net income:** -$20.1M (USD -20,132,000)
- **Total assets:** $153.5M (USD 153,524,000)
- **Cash and equivalents:** $12.1M (USD 12,058,000)
- **Operating cash flow:** -$14.3M (USD -14,261,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $54.1M (USD 54,129,000)
- **Net income:** -$18.1M (USD -18,107,000)
- **Total assets:** $42.6M (USD 42,602,000)
- **Cash and equivalents:** $5.3M (USD 5,274,000)
- **Operating cash flow:** -$10.0M (USD -9,975,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $59.0M (USD 59,029,000)
- **Net income:** -$4.4M (USD -4,372,000)
- **Total assets:** $58.5M (USD 58,520,000)
- **Cash and equivalents:** $16.5M (USD 16,510,000)
- **Operating cash flow:** -$3.2M (USD -3,224,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $50.8M (USD 50,820,000)
- **Net income:** -$5.3M (USD -5,339,000)
- **Total assets:** $50.9M (USD 50,855,000)
- **Cash and equivalents:** $11.2M (USD 11,208,000)
- **Operating cash flow:** -$2.2M (USD -2,193,000)

## Recent SEC filings

- Form 8-K — filed 2024-09-16 — period 2024-09-16 — FORM 8-K
- Form 8-K — filed 2024-09-11 — period 2024-09-11 — FORM 8-K
- Form 8-K — filed 2024-09-10 — period 2024-09-04 — FORM 8-K
- Form 8-K — filed 2024-09-10 — period 2024-09-10 — FORM 8-K
- Form 10-Q — filed 2024-08-07 — period 2024-06-30 — FORM 10-Q
- Form 8-K — filed 2024-08-06 — period 2024-08-06 — FORM 8-K
- Form 8-K — filed 2024-07-23 — period 2024-07-17 — FORM 8-K
- Form 8-K — filed 2024-06-24 — period 2024-06-19 — FORM 8-K
- Form 8-K — filed 2024-06-24 — period 2024-06-21 — FORM 8-K
- Form 10-Q — filed 2024-05-14 — period 2024-03-31 — 10-Q
- Form 8-K — filed 2024-05-14 — period 2024-05-14 — 8-K
- Form 10-K/A — filed 2024-04-29 — period 2023-12-31 — 10-K/A

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/alimera-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology